|
RAD18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.335820E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.500300E-02 |
| Normal-vs-Stage2 |
3.591700E-02 |
| Normal-vs-Stage3 |
1.373350E-04 |
| Normal-vs-Stage4 |
4.945000E-01 |
| Stage1-vs-Stage2 |
4.600400E-01 |
| Stage1-vs-Stage3 |
4.039900E-03 |
| Stage1-vs-Stage4 |
5.823600E-01 |
| Stage2-vs-Stage3 |
2.312800E-01 |
| Stage2-vs-Stage4 |
3.931600E-01 |
| Stage3-vs-Stage4 |
9.309500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.869800E-02 |
| Normal-vs-AfricanAmerican |
6.777800E-04 |
| Normal-vs-Asian |
5.140000E-01 |
| Caucasian-vs-AfricanAmerican |
2.214300E-02 |
| Caucasian-vs-Asian |
8.926000E-01 |
| AfricanAmerican-vs-Asian |
3.006600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.240300E-02 |
| Normal-vs-Female |
5.021000E-03 |
| Male-vs-Female |
6.858200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.105400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.385900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.506110E-02 |
| Normal-vs-Age(81-100Yrs) |
7.213000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.450200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.310600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.718400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.241200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.136400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.750200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.052800E-01 |
| Normal-vs-Grade 2 |
3.719900E-02 |
| Normal-vs-Grade 3 |
5.415100E-04 |
| Normal-vs-Grade 4 |
4.145600E-01 |
| Grade 1-vs-Grade 2 |
6.458600E-01 |
| Grade 1-vs-Grade 3 |
1.325990E-01 |
| Grade 1-vs-Grade 4 |
8.377600E-01 |
| Grade 2-vs-Grade 3 |
6.202000E-03 |
| Grade 2-vs-Grade 4 |
8.345200E-01 |
| Grade 3-vs-Grade 4 |
2.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.208310E-02 |
| Normal-vs-ccB subtype |
1.595790E-01 |
| ccA subtype-vs-ccB subtype |
2.162800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.518400E-02 |
| Normal-vs-N1 |
5.824200E-01 |
| N0-vs-N1 |
6.669800E-01 |
|
|
